Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma.

Guilherme Nader Marta Leonardo Gomes da Fonseca Maria Ignez Freitas Melro Braghiroli Fernando Moura Paulo Marcelo Gehm Hoff Jorge Sabbaga

Published in: Clinics (Sao Paulo, Brazil) (2021)

Efficacy and safety of sorafenib did not differ significantly between younger and older patients with HCC. Our data suggest that age alone should not restrict clinical decision-making for patients with advanced HCC.

Keyphrases

decision making
electronic health record
middle aged
big data
data analysis